Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of McCormick & Schmick’s Seafood Restaurants, Inc. (“McCormick & Schmick” or the “Company”) (Nasdaq - MSSR) relating to the proposed acquisition by a subsidiary of Landry’s Inc. Under the terms of the transaction McCormick & Schmick shareholders would receive $8.75 in cash for each share McCormick & Schmick stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of McCormick & Schmick for not acting in the Company’s shareholders' best interests in connection with the sale process to Landry’s. The transaction may undervalue McCormick & Schmick as McCormick & Schmick stock traded at $11.64 on April 14, 2010 and traded at $9.26 as recently as July 21, 2011. In addition, in April of 2011 the Company adopted a poison pill to prevent a hostile takeover at $9.25 per share. If you own shares of McCormick & Schmick stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at email@example.com, visiting http://brodsky-smith.com/357-mssr-mccormick--schmicks-seafood-restaurants-inc.html, or by calling toll free 877-LEGAL-90.
Billionaire Carl Icahn is trying to take control of all the seats on Clorox's board after the company twice rejected his takeover bids. Find out which other consumer stocks are joining the M&A uptrend.